Why Verastem Is Knocking It Out of the Park
Verastem saw perhaps the biggest gain in the market Wednesday after the company announced positive late-stage results.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 159
Half of Americans Tested Misuse Their Prescription Medications
A study found that while evidence of misuse has declined in recent years, more than half of test results showed evidence of potential misuse, suggesting most patients took their prescribed drugs in ways inconsistent…
Sarepta Therapeutics Surges Following Duchenne Muscular Dystrophy Trial
Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its mid-stage study for the treatment of Duchenne muscular dystrophy.
Rhythm Pharmaceuticals Files for IPO
Biopharmaceutical company Rhythm Pharmaceuticals has with the SEC regarding its initial public offering.
How Insmed Is Capitalizing on Its Huge Late-Stage Success
Insmed has filed with the SEC for a secondary offering. This follows a surge in the share price following positive late-stage results from its clinical study in the treatment of nontuberculous mycobacteria lung disease.
Deaths Linked to Drug Overdoses Surge in US
Drug overdose deaths for the 12 months ending January 2017 rose 21%, according to data from the CDC. Maryland led in drug-abuse deaths in more than one category.
FDA Crushes Cellectis With Clinical Hold
Cellectis shares tumbled early on Tuesday after the firm announced that a couple of its early-stage studies were put on hold by the FDA.
BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win
BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its mid-stage clinical trial in hereditary angioedema.
Insmed More Than Doubles on Late-Stage Trial
Insmed saw its shares more than double early on Tuesday after the firm released late-stage results from its clinical study in the treatment of nontuberculous mycobacteria lung disease.
FDA Crushes SteadyMed With Refusal to File Letter
SteadyMed shares plummeted after the firm had a setback from the FDA regarding its pulmonary arterial hypertension treatment.
1.5 Million Americans a Year Make Medication Errors
Taking more than a prescribed amount of medication leads to nearly 1.5 million calls annually to U.S. poison control centers.
ImmunoGen Riding High on Jazz Pharma Deal
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
Mazor Robotics Jumps After Medtronic Collaboration Update
Mazor Robotics saw its shares make a handy gain to kick off hump day after it was announced that the company has entered the next phase of its strategic partnership with Medtronic earlier than…
Why Otonomy Shares Are Getting Absolutely Crushed
Otonomy saw its shares crater after the firm announced results for its Averts-1 late-stage trial of Otividex in patients with Ménière’s disease.
ImmunoGen and Jazz Enter Into Global Collaboration
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.